Infinity Pharmaceuticals Performance

Infinity Pharmaceuticals Inc -- USA Stock  

USD 2.70  0.11  4.25%

Infinity Pharmaceuticals holds performance score of 14 on a scale of zero to a hundred. The company retains Market Volatility (i.e. Beta) of -0.3867 which attests that as returns on market increase, returns on owning Infinity Pharmaceuticals are expected to decrease at a much smaller rate. During bear market, Infinity Pharmaceuticals is likely to outperform the market.. Although it is essential to pay attention to Infinity Pharmaceuticals current price history, it is also good to be reasonable about what you can actually do with equity current price movements. Macroaxis philosophy towards determining future performance of any stock is to look not only at its past charts but also at the business as a whole, including all fundamental and technical indicators. To evaluate if Infinity Pharmaceuticals expected return of 1.9371 will be sustainable into the future, we have found twenty-one different technical indicators which can help you to check if the expected returns are sustainable. Use Infinity Pharmaceuticals Inc Treynor Ratio, and the relationship between Standard Deviation and Downside Variance to analyze future returns on Infinity Pharmaceuticals Inc.
 Time Horizon     30 Days    Login   to change

Infinity Pharmaceuticals Relative Risk vs. Return Landscape

If you would invest  186.00  in Infinity Pharmaceuticals Inc on February 15, 2018 and sell it today you would earn a total of  73.00  from holding Infinity Pharmaceuticals Inc or generate 39.25% return on investment over 30 days. Infinity Pharmaceuticals Inc is currenly generating 1.9371% of daily expected returns and assumes 8.8644% risk (volatility on return distribution) over the 30 days horizon. In different words, 82% of equities are less volatile than Infinity Pharmaceuticals Inc and 64% of traded equity instruments are projected to make higher returns than the company over the 30 days investment horizon.
 Daily Expected Return (%) 
      Risk (%) 
Given the investment horizon of 30 days, Infinity Pharmaceuticals Inc is expected to generate 9.27 times more return on investment than the market. However, the company is 9.27 times more volatile than its market benchmark. It trades about 0.22 of its potential returns per unit of risk. The DOW is currently generating roughly -0.05 per unit of risk.

Operating Margin

Infinity Pharmaceuticals Operating Margin
Based on recorded statements Infinity Pharmaceuticals Inc has Operating Margin of -789.3%. This is 2299.82% higher than that of the Healthcare sector, and significantly lower than that of Pharmaceutical Products industry, The Operating Margin for all stocks is 7134.65% higher than the company.
A good Operating Margin is required for a company to be able to pay for its fixed costs or pay out its debt which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against firm's competitors.

Infinity Pharmaceuticals Daily Price Distribution

The median price of Infinity Pharmaceuticals for the period between Thu, Feb 15, 2018 and Sat, Mar 17, 2018 is 2.07 with a coefficient of variation of 16.32. The daily time series for the period is distributed with a sample standard deviation of 0.36, arithmetic mean of 2.19, and mean deviation of 0.33. The Stock received some media coverage during the period.

Risk-Adjusted Performance

Compared to the overall equity markets, risk-adjusted returns on investments in Infinity Pharmaceuticals Inc are ranked lower than 14 (%) of all global equities and portfolios over the last 30 days.

One Month Efficiency

Infinity Pharmaceuticals Sharpe Ratio = 0.2185
Good Returns
Average ReturnsINFI
Small Returns
Negative Returns

Estimated Market Risk

  actual daily
 18 %
of total potential

Expected Return

  actual daily
 37 %
of total potential

Risk-Adjusted Return

  actual daily
 14 %
of total potential
Based on monthly moving average Infinity Pharmaceuticals is performing at about 14% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Infinity Pharmaceuticals by adding it to a well-diversified portfolio.